3 days agoDoW Adds $3.3 Million to MediWound’s NexoBrid Development Program
The U.S. Department of War added $3.3 million for a room-temperature-stable NexoBrid formulation intended for battlefield burn care, bringing the program budget to $21.8 million. Separately, BARDA-related purchases through Vericel’s contract are expected to continue through Q1 2027; neither activity represents a newly announced solicitation.
18 days agoCanada Awards SIGA Up to $15 Million for TPOXX Supply Through 2031
Public Services and Procurement Canada awarded SIGA Technologies a follow-on contract to supply oral TPOXX to Canada’s Department of National Defence through March 31, 2031. The award is valued at up to approximately $15 million, including about $9 million in firm commitments and $6 million dependent on option exercise, signaling sustained Canadian demand for smallpox countermeasures.
79 days agoBARDA Invests $36.9M in Fetroja for National Biodefense Initiative
In August 2026, BARDA exercised a $36.9 million option under a significant contract with Shionogi Inc. for Fetroja, an antibiotic targeting drug-resistant infections. This contract, part of Project BioShield, underlines a robust federal commitment to enhancing medical countermeasures against biothreats, creating opportunities for suppliers in the healthcare sector.